Donald Gao

Partner

Ray Yang

Partner

Yiran Song

Managing Director

Tang Yinan

Managing Director

52 past transactions

Medical Image Insights

Series A in 2025
Medical Image Insights is a company that specializes in medical imaging AI integration and R&D. It provide medical imaging professionals with AI and statistical-based medical imaging auxiliary tools, as well as its own medical imaging AI solutions.

Femtosecond Technology

Series A in 2024
Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.

Natus

Seed Round in 2024
Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity, the company has become a partner of many domestic laboratories.

Kangai Medical

Series A in 2024
Kangai Medical specialises on clinical nutrition and rehabilitation

Minglan Shijia

Seed Round in 2023
Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.

Bingjing Smart

Seed Round in 2023
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.

Neowise

Series A in 2023
XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.

Botong Medical

Seed Round in 2023
Botong Medical is a comprehensive service platform created for the management of cancer pain. The business's data platform, digital medical goods, focuses on intelligent pain assessment, fracture risk prediction, chronic pain management, and rehabilitation. It offers stepped pain treatment services to both cancer pain patients and chronic pain patients.

Botong Medical

Angel Round in 2022
Botong Medical is a comprehensive service platform created for the management of cancer pain. The business's data platform, digital medical goods, focuses on intelligent pain assessment, fracture risk prediction, chronic pain management, and rehabilitation. It offers stepped pain treatment services to both cancer pain patients and chronic pain patients.

bio Genous

Seed Round in 2022
bio Genous provides biomedical scientific research, drug development, and clinical precision medicine services. They offer services that include organoid automation equipment, multi-tissue full-process kits, organoid culture and sample library construction technical solutions, organoid drug development, and precision medical subsystems.

SprintRay

Series D in 2022
SprintRay is a manufacturer of 3D printing technology specifically designed for the dental industry. Founded in 2014, the company focuses on creating advanced, user-friendly products that empower dental professionals to enhance their services and respond swiftly to patient needs. By providing comprehensive additive manufacturing solutions, SprintRay aims to transform digital dentistry and expand the applications of desktop 3D printing in various sectors. The company's commitment to accessibility and reliability positions it as a forward-thinking player in the market, dedicated to improving the efficiency of dental practices and enhancing patient care.

Xunshi Technology

Series D in 2022
Zhejiang Xunshi Technology Co., Ltd. specializes in the development and manufacturing of 3D printers, printing consumables, and 3D scanners. The company offers a range of desktop printers tailored for specific sectors, including the MoonRay D for dental applications, MoonRay J for jewelry, and MoonRay S for educational purposes. Its industrial printer lineup features the SLA laser rapid prototyping printer, the SolarRay DLP 3D printer, and ceramic 3D printers such as the CeraRay CR-I and CeraRay TC-I. Additionally, Xunshi produces 3D architectural printers designed for contour crafting and provides photosensitive resin and photocurable wax products for dentistry, jewelry, and ceramics. The company's desktop scanners serve various applications in dental medicine, education, research, and industry. Established in 2013, Xunshi Technology is headquartered in Shaoxing, China.

Bingjing Smart

Angel Round in 2022
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.

Bingjing Smart

Seed Round in 2022
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.

Yuanyi Biotech

Seed Round in 2022
Yuanyi Biotech is specialized in creating artificial microbial technology and products. It designs and builds new gene metabolic pathways using "engineering" thinking and effective gene editing tools, creating cell factories with extremely high productivity, and offering one-stop solutions for integrated strain development, fermentation process optimization, industrial fermentation production, and product development.

Doctor AI Yisheng Intelligence

Series A in 2021
Doctor AI is a med-tech firm that provides a smart AI medical record quality control system.

AYR.ai

Series A in 2021
AYR.ai is an artificial intelligence platform that specializes in transforming raw data into actionable insights for enterprises. The platform leverages natural language processing, image processing, and predictive analytics to assist business users in automating the entire life cycle of AI projects. This includes the processes of labeling, training, modeling, deploying, and maintaining AI systems. By providing practical, scalable, and cost-effective AI solutions, AYR.ai enables businesses to efficiently harness the power of AI to enhance their operations and decision-making capabilities.

OrthoGuard

Series A in 2021
OrthoGuard Physicians is a comprehensive orthopedic medical service organization based in China, focusing on the treatment and diagnosis of various musculoskeletal conditions, including joint, spine, ankle, and trauma injuries. The company emphasizes efficient management and innovative operational models to enhance patient care, facilitating quicker healing and improved recovery experiences. In addition to direct medical services, OrthoGuard is involved in hospital management, rehabilitation services, and education and training initiatives. The organization also engages in supply chain management and the establishment of demonstration diagnosis and treatment centers, aiming to create a reputable and innovative medical group in the orthopedic field. Through these efforts, OrthoGuard seeks to leverage its extensive resources and expertise to advance orthopedic healthcare in China.

Lianbo Precision

Series A in 2021
Jiangsu Lianbo Precision Technology Co., Ltd., established in June 2008, specializes in the development and manufacturing of high-end automotive motors and super-precision rotors. The company occupies a production facility exceeding 30,000 square meters and employs around 200 individuals. With a commitment to quality, Lianbo Precision imports advanced high-speed punch machinery and testing equipment, enabling an annual production capacity of over 60,000 tons and a potential output value of 500 million yuan. The company primarily produces rotors for various applications, including EPS motors, ABS motors, cooling fan motors, starter motors, glass lifter motors, and components for new energy vehicles and motorcycles. Additionally, Lianbo Precision manufactures stators and rotors for household appliances and industrial motors. Its client base includes prominent manufacturers from the United States, Japan, Germany, and France, reflecting the company's reputation for providing specialized support to multinational enterprises and leading automotive parts manufacturers globally.

Shangyong Technology

Series C in 2021
Shanghai Shangyong Technology focuses on providing digital solutions specifically for life insurance risk management and health management services. The company has developed an insurance platform that leverages big data technology to create risk control models applicable to various types of insurance, including life, critical illness, medical, and accident insurance. By quantifying health and credit risk levels, Shangyong Technology enables customers to receive tailored insurance products that meet their individual needs. This innovative approach enhances the overall efficiency and effectiveness of insurance risk management.

MediTrust Health

Series C in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.

Connect Medical Value Technology

Series A in 2021
Connect Medical Value Technology is a company established in 2020 and based in Hangzhou, Zhejiang, China. It specializes in developing mobile applications designed for physicians, offering a comprehensive platform that integrates clinical services, scientific research, and educational resources. The company's applications leverage advanced artificial intelligence technology to enhance medical practice and improve healthcare delivery. Through its innovative solutions, Connect Medical Value aims to support healthcare professionals in their clinical decision-making and ongoing education.

MediTrust Health

Series B in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.

Singular Medical

Series B in 2021
Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.

Singular Medical

Series A in 2020
Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.

Xunshi Technology

Series B in 2019
Zhejiang Xunshi Technology Co., Ltd. specializes in the development and manufacturing of 3D printers, printing consumables, and 3D scanners. The company offers a range of desktop printers tailored for specific sectors, including the MoonRay D for dental applications, MoonRay J for jewelry, and MoonRay S for educational purposes. Its industrial printer lineup features the SLA laser rapid prototyping printer, the SolarRay DLP 3D printer, and ceramic 3D printers such as the CeraRay CR-I and CeraRay TC-I. Additionally, Xunshi produces 3D architectural printers designed for contour crafting and provides photosensitive resin and photocurable wax products for dentistry, jewelry, and ceramics. The company's desktop scanners serve various applications in dental medicine, education, research, and industry. Established in 2013, Xunshi Technology is headquartered in Shaoxing, China.

Ruiyi Biotechnology (Realbio Technology)

Series A in 2019
Shanghai Ruiyi Biotechnology Co., Ltd., established in 2014, is a national high-tech enterprise based in Shanghai, with additional branches in Hangzhou, Qingdao, and Guiyang. The company specializes in genetic technology and health services, focusing on microbial gene technology for tumor detection and intestinal microecology analysis. Ruiyi Biotechnology employs next-generation sequencing platforms and advanced computing capabilities to conduct extensive genetic research, sequencing, and bioinformatics analysis. It provides high-precision testing services in microbiota and oncology for healthcare practitioners and researchers. The company has formed partnerships with numerous renowned research institutes both domestically and internationally, and it has secured over 40 software copyrights along with several patents, attracting talent from genomics, medicine, and bioinformatics.

Shukun

Series B in 2019
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Aqara

Series B in 2018
Aqara is a prominent smart home brand that specializes in developing innovative smart home appliances and IoT solutions for both consumers and industrial applications. The company focuses on enhancing daily life by simplifying routine tasks through a diverse range of high-quality, cost-effective products. Aqara's offerings are distinguished by their elegant industrial design and the integration of advanced AI and data analysis systems, allowing for customization to meet individual lifestyle needs. As a result, Aqara has gained a reputation for reliability and efficiency in the smart home market.

DaoCloud

Series B in 2018
DaoCloud, founded in late 2014, is a leader in the cloud-native technology sector, specializing in cloud-based docker container solutions. The company focuses on transforming how applications are created and delivered by providing a continuous integration toolchain that streamlines the development process from inception to final release. With a commitment to facilitating digital transformation for enterprises, DaoCloud leverages its proprietary intellectual property to offer an open Cloud Operating System. Its innovative approaches have been applied across various industries, including Fintech, advanced manufacturing, smart vehicles, retail, and urban intelligence initiatives.

GrandOmics

Series B in 2018
GrandOmics is a biotechnology company that specializes in molecular diagnostics and genetic testing services, primarily targeting single-gene diseases. The company develops and utilizes advanced sequencing technologies, including single-molecule, real-time sequencing, to enhance disease detection. GrandOmics offers a comprehensive platform known as GrandBox, which integrates clinical sample management, data standard analysis, and visualization reporting. This platform serves as a centralized solution for clinical laboratories, enabling efficient management and analysis of genetic disease sequencing data. Through its innovative approach, GrandOmics aims to provide accurate, reliable, and scientifically rigorous genetic testing services that support both research and clinical applications.

Shukun

Series A in 2018
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Nanos Medical

Series B in 2018
Nanos Medical specializes in the research, development, manufacturing, and sales of disposable medical devices, primarily targeting the cardiovascular and ear, nose, and throat (ENT) fields. The company offers a range of innovative products, including sinus balloon catheters, eustachian tube balloons, disposable nasopharyngeal airways, nasolacrimal balloons, and drug-eluting stents for sinus applications. Through its advanced medical devices, Nanos Medical aims to enhance treatment options for hospitals and patients, contributing to improved healthcare outcomes.

Vedeng

Series A in 2018
Vedeng operates an online procurement platform in China that facilitates the sourcing of medical devices. The company's platform connects upstream manufacturers with medical equipment dealers and private clinics, streamlining the procurement process for buyers. Vedeng has developed a comprehensive digital infrastructure that includes front-end marketing, procurement systems, logistics, after-sales service, and back-end commodity databases. This extensive network serves approximately 970,000 grassroots and private medical customers, enhancing accessibility and efficiency in the medical equipment market.

MediTrust Health

Angel Round in 2018
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.

V-Joy Tech Group

Series A in 2018
V-Joy Tech Group is a provider of financial software focused on serving the financial sector in China. The company's offerings include solutions for data management, data risk control, and payroll services. By enabling clients to manage their data effectively and conduct secure transactions, V-Joy Tech Group aims to enhance operational efficiency and risk management within the financial industry.

Hofon Medical Care

Series A in 2018
Hofon Medical Care is a provider of medical and health services dedicated to meeting the healthcare needs of community residents. The company has developed an integrated online and offline service model that facilitates access to disease diagnosis and treatment, home-based medical care, chronic disease management, and health management services. By focusing on the health status and medical service demands of the community, Hofon Medical Care aims to offer convenient, efficient, and high-quality one-stop medical services, ensuring that patients can receive essential care close to home.

Huangjinguanjia

Series B in 2018
Huangjinguanjia is an online financial service platform headquartered in Beijing, China, specializing in gold trading and investment. The company offers a range of online financial services aimed at facilitating investments in gold, catering to both individual and institutional clients looking to enter the precious metals market. By leveraging technology, Huangjinguanjia aims to provide a seamless and efficient trading experience for its users.

Cihon Technology

Series B in 2018
Cihon Technology is a digital intelligence service platform specializing in data analytics for the automotive industry. The company offers insights on vehicles, auto parts, and vehicle owners, primarily catering to car manufacturers and insurance providers. By leveraging its data analytics capabilities, Cihon Technology aims to enhance business operations within the automotive sector.

JuniperMD

Angel Round in 2018
JuniperMD Inc. is a disease management service organization headquartered in Beijing, China, with additional offices in cities such as Guangzhou, Shanghai, New York, Boston, Chicago, and Houston. Established in 2016, the company integrates medical resources from the United States, Australia, Japan, and Europe to deliver comprehensive disease management solutions tailored for the Chinese market. Its offerings encompass overseas medical examinations, pathological assessments, remote diagnostics and consultations, as well as international medical treatments and follow-up services. JuniperMD emphasizes a collaborative approach, utilizing professional expertise and advanced technology to address various aspects of healthcare, including prevention, investigation, diagnosis, and treatment. The company also engages in multidisciplinary dialogue and maintains partnerships with international physicians to enhance its consulting services.

Lion Rock FinTech

Series A in 2017
Lion Rock FinTech is a startup company that provides commercial financing services. The company focuses on worldwide financial asset allocation and has built a financial services platform that incorporates fund sales, asset management, and financial media. It enables investors to obtain extensive information on wealth management products.

Yidebang

Series A in 2017
Yidebang is a Beijing-based healthcare software developer, which provides management solution, drug supply, hierarchical diagnosis and treatment and other supporting medical services for basic-level clinics in China.

AnchorDx

Series B in 2017
AnchorDx is a biotechnology company specializing in next-generation sequencing techniques, particularly through the use of molecular liquid biopsies. This innovative approach allows for non-invasive access to genetic information, enabling patients to gain insights into their physiological conditions and better prepare for potential health issues. With a core team boasting over 20 years of experience in cancer genomics, genetics, and bioinformatics, AnchorDx aims to lead in precision medicine by developing comprehensive clinical applications and research platforms. The company fosters collaborations with various stakeholders, including hospitals, research institutes, and third-party testing agencies, to create a complete industrial chain that facilitates the transformation of academic research into clinical products. Through its commitment to developing independent intellectual property and competitive clinical testing solutions, AnchorDx provides accurate and comprehensive services to patients, healthcare providers, and medical institutions.

Helian Health

Series A in 2017
Helian Health, established in 2014 and headquartered in Hangzhou, China, specializes in providing Wi-Fi services to hospitals and developing online healthcare applications that support both patients and medical professionals. The company has created several applications, such as Xiaohe Yizhu, which enables healthcare providers to store health records in the cloud and share medical insights, and Hejiankang, which offers personalized health recommendations for employees. By focusing on the Internet of Things in healthcare, Helian Health has signed agreements with over 1,700 hospitals across 245 cities, including numerous top-tier facilities, thereby establishing itself as a leading Wi-Fi service provider within the sector. Additionally, the company offers various health management solutions that interpret personal health data and create tailored wellness programs for organizations. Through partnerships and innovative technology, Helian Health aims to enhance patient care and operational efficiency in medical institutions.

Baozhunniu

Series B in 2017
Baozhunniu is an online insurance platform that specializes in delivering customized insurance products tailored to the needs of both enterprises and individuals. The company employs a data-driven approach to address the limitations of traditional insurance models, allowing clients to manage risks across a diverse array of categories such as sports, employment, and international activities. By offering innovative and flexible insurance solutions, Baozhunniu aims to enhance accessibility and personalization within the insurance market.

Shukun

Angel Round in 2017
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

GEvent Financial Service

Series A in 2017
GEvent Financial Service, headquartered in Nanjing, China, specializes in providing internet-based financial services tailored for banks and non-bank financial institutions. Their offerings include bank wealth management services and asset management product exchanges, facilitated through an online platform. The company also provides technical support and other related services to enhance banking and wealth management capabilities of its clients.

Ziasset Intelligent Technology

Angel Round in 2016
Ziasset Intelligent Technology is a technology-based company that has entered the financial sector with artificial intelligence as its core technology. It has remained committed to serving the financial market through artificial intelligence algorithms. The company intends to establish an artificial intelligence version of the domestic capital market as its foothold.

Yisheng Hui

Series A in 2016
Yisheng Hui is an Internet-based medical technology company with the objectives of increasing doctors' professional skills and sunshine income as its mission and helping doctors as its main strategic focus. Whether it's a clinical database, media matrix, live medical video broadcast, Doctor Connect APP, or community, doctors can increase their professional abilities and work efficiency in a variety of ways with the use of doctor tools, doctor-medical collaboration, and other dimensional requirements.

Hulianwang

Series A in 2016
Hulianwang is a provider of career development services intended for nursing professionals. The company offers professional and technical education for nurses, nursing career recruitment, study abroad programs, and academic advisory services, providing nurses with the tools necessary to begin their careers.

AnchorDx

Series A in 2015
AnchorDx is a biotechnology company specializing in next-generation sequencing techniques, particularly through the use of molecular liquid biopsies. This innovative approach allows for non-invasive access to genetic information, enabling patients to gain insights into their physiological conditions and better prepare for potential health issues. With a core team boasting over 20 years of experience in cancer genomics, genetics, and bioinformatics, AnchorDx aims to lead in precision medicine by developing comprehensive clinical applications and research platforms. The company fosters collaborations with various stakeholders, including hospitals, research institutes, and third-party testing agencies, to create a complete industrial chain that facilitates the transformation of academic research into clinical products. Through its commitment to developing independent intellectual property and competitive clinical testing solutions, AnchorDx provides accurate and comprehensive services to patients, healthcare providers, and medical institutions.

GEvent Financial Service

Angel Round in 2014
GEvent Financial Service, headquartered in Nanjing, China, specializes in providing internet-based financial services tailored for banks and non-bank financial institutions. Their offerings include bank wealth management services and asset management product exchanges, facilitated through an online platform. The company also provides technical support and other related services to enhance banking and wealth management capabilities of its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.